# PASS OCT® Post-market Clinical Follow-up

> **NCT02931279** · — · COMPLETED · sponsor: **Medicrea International** · enrollment: 40 (estimated)

## Conditions studied

- Intervertebral Disc Disease
- Spondylolisthesis
- Spinal Stenosis
- Spinal Neoplasms
- Spinal Fractures

## Interventions

- **DEVICE:** PASS OCT® Spinal System

## Key facts

- **NCT ID:** NCT02931279
- **Lead sponsor:** Medicrea International
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931279, "PASS OCT® Post-market Clinical Follow-up". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02931279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*